These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38269640)

  • 1. EBNEO Commentary: De-MIST-ifying the 2-year outcomes of non-invasive surfactant therapy.
    Loft L; Ferguson KN; Tingay DG
    Acta Paediatr; 2024 May; 113(5):1121-1122. PubMed ID: 38269640
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less invasive surfactant administration by umbilical catheter is safe and effective for treating respiratory distress syndrome in preterm infants.
    Truong TT; Tran HT; Skinner A; Narchi H
    Acta Paediatr; 2023 Apr; 112(4):706-707. PubMed ID: 36579363
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive Ventilation and Exogenous Surfactant in Times of Ever Decreasing Gestational Age: How Do We Make the Most of These Tools?
    Wright CJ; Glaser K; Speer CP; Härtel C; Roehr CC
    J Pediatr; 2022 Aug; 247():138-146. PubMed ID: 35429507
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant delivery strategies to prevent bronchopulmonary dysplasia.
    Kribs A; Roberts KD; Trevisanuto D; O'Donnell C; Dargaville PA
    Semin Perinatol; 2023 Oct; 47(6):151813. PubMed ID: 37805275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
    JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 11. Timing of surfactant treatment in respiratory distress syndrome.
    van Kaam AH; Niemarkt HJ; Onland W
    Semin Fetal Neonatal Med; 2023 Dec; 28(6):101495. PubMed ID: 38012889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal invasive surfactant therapy in preterm infants with respiratory distress syndrome: a single-center experience.
    Rallis D; Drogouti E; Karagianni P; Soubasi-Griva V; Tsakalidis C
    Minerva Pediatr (Torino); 2024 Feb; 76(1):72-78. PubMed ID: 33820400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory management in the premature neonate.
    Dumpa V; Avulakunta I; Bhandari V
    Expert Rev Respir Med; 2023 Feb; 17(2):155-170. PubMed ID: 36803028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimal invasive surfactant therapy: experience from a low resource setting.
    Ajanwaenyi J; Bamidele O; Osim C; Salami O; Umukoro C; Idaboh T; Chimah U; Okolo A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5177-5183. PubMed ID: 33491516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBNEO Commentary: OPTIMIST-ically moving towards targeted noninvasive surfactant therapy?
    Wright CJ; Glaser K; Bamat NA
    Acta Paediatr; 2022 May; 111(5):1091-1092. PubMed ID: 35100470
    [No Abstract]   [Full Text] [Related]  

  • 19. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study).
    Corsini I; Rodriguez-Fanjul J; Raimondi F; Boni L; Berardi A; Aldecoa-Bilbao V; Alonso-Ojembarrena A; Ancora G; Aversa S; Beghini R; Meseguer NB; Capasso L; Chesi F; Ciarcià M; Concheiro A; Corvaglia L; Ficial B; Filippi L; Carballal JF; Fusco M; Gatto S; Ginovart G; Gregorio-Hernández R; Lista G; Sánchez-Luna M; Martini S; Massenzi L; Miselli F; Mercadante D; Mosca F; Palacio MT; Perri A; Piano F; Prieto MP; Fernandez LR; Risso FM; Savoia M; Staffler A; Vento G; Dani C
    Trials; 2023 Nov; 24(1):706. PubMed ID: 37925512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.